FOLFOX-4
Showing 1 - 25 of >10,000
Post-orthotopic Liver Transplantation, Hepatocellular Carcinoma Recurrent Trial in Nanjing (Bevacizumab Biosimilar IBI305)
Not yet recruiting
- Post-orthotopic Liver Transplantation
- Hepatocellular Carcinoma Recurrent
- Bevacizumab Biosimilar IBI305
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
May 5, 2022
Advanced Hepatocellular Carcinoma Trial in Nanjing (SHR-1210, FOLFOX4, Placebo)
Recruiting
- Advanced Hepatocellular Carcinoma
- SHR-1210
- +2 more
-
Nanjing, Jiangsu, China81 Hospital Nanjing
Feb 9, 2022
Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX Trial in Kaunas (Radiotherapy 50 Gy, Fluorouracil/folic acid,
Recruiting
- Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
- Radiotherapy 50 Gy
- +2 more
-
Kaunas, LithuaniaRita Ambraziene
May 12, 2022
Advanced Primary Liver Cancer, Advanced Biliary Tract Carcinoma Trial in Zhengzhou, Nanjing (SHR-1210, Apatinib, FOLFOX4)
Active, not recruiting
- Advanced Primary Liver Cancer
- Advanced Biliary Tract Carcinoma
- SHR-1210
- +3 more
-
Zhengzhou, Henan, China
- +1 more
Apr 26, 2022
Locally-advanced Rectal Cancer Trial in Lyon, Villejuif (mFOLFIRINOX, Pelvic radiotherapy LCRT, Capecitabine)
Not yet recruiting
- Locally-advanced Rectal Cancer
- mFOLFIRINOX
- +6 more
-
Lyon, Rhöne, France
- +1 more
Jun 12, 2023
Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)
Not yet recruiting
- Colonic Neoplasms
- Dostarlimab
- +2 more
- (no location specified)
May 3, 2023
Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- Chemotherapy Effect
- FOLFOX chemotherapy regimens
- Bevacizumab
-
GuangZhou, Guangdong, ChinaThe Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Not yet recruiting
- Metastatic Colon Adenocarcinoma
- +6 more
- Balstilimab
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 17, 2022
Hepatocellular Carcinoma Trial in Malaysia, Thailand (biological, drug, other)
Not yet recruiting
- Hepatocellular Carcinoma
- AlloStim® immunotherapy
- +2 more
-
Pulau Pinang, George Town, Malaysia
- +7 more
Aug 30, 2021
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial
Not yet recruiting
- Advanced Esophageal Adenocarcinoma
- +14 more
- Fluorouracil
- +8 more
- (no location specified)
Jan 3, 2023
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +5 more
- Biospecimen Collection
- +9 more
-
Scottsdale, Arizona
- +2 more
Oct 11, 2023
Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus
Terminated
- Advanced Gastrointestinal (GI) Malignancies
- +3 more
- ADI-PEG 20 plus modified FOLFOX6
-
San Francisco, California
- +34 more
Apr 18, 2022
Operable T2-3N+M0 Rectal Cancer (Stage III) Trial in Canada (FOLFOX, high dose rate endorectal brachytherapy)
Active, not recruiting
- Operable T2-3N+M0 Rectal Cancer (Stage III)
- FOLFOX
- high dose rate endorectal brachytherapy
-
Gatineau, Quebec, Canada
- +7 more
May 13, 2021
Hepatocellular Carcinoma Trial in Shanghai (FOLFOX4(infusional fluorouracil [FU], leucovorin [LV], and oxaliplatin [OXA]).)
Not yet recruiting
- Hepatocellular Carcinoma
- FOLFOX4(infusional fluorouracil [FU], leucovorin [LV], and oxaliplatin [OXA]).
-
Shanghai, Shanghai, ChinaEastern hepatobilliary surgery hospital
Aug 19, 2020
Metastatic Gastro-esophageal Adenocarcinoma Trial in Regina, Saskatoon (FOLFOX and FOLFIRI)
Terminated
- Metastatic Gastro-esophageal Adenocarcinoma
- FOLFOX and FOLFIRI
-
Regina, Saskatchewan, Canada
- +1 more
Oct 29, 2020
Metastatic Colorectal Cancer Trial in France, Martinique (FOLFOX + panitumumab)
Recruiting
- Metastatic Colorectal Cancer
- FOLFOX + panitumumab
-
Sainte Colombe, Lyon, France
- +45 more
Mar 23, 2022
Colonic Cancer, Unresectable Metastasis Originating in Colonic Cancer Trial in Spain (Colonic resection, Chemotherapy- scheme)
Terminated
- Colonic Cancer
- Unresectable Metastasis Originating in Colonic Cancer
- Colonic resection
- Chemotherapy- scheme
-
Vitoria/Gasteiz, Araba, Spain
- +21 more
Mar 12, 2021
Rectal Cancer Trial in Madison (FOLFOX4, Cetuximab)
Terminated
- Rectal Cancer
-
Madison, WisconsinUniversity of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Dec 11, 2019
Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)
Recruiting
- Locally Advanced Colorectal Carcinoma
- Cadonilimab
- FOLFOX regimen
-
Beijing, Beijing, ChinaCancer Hospital/ National Cancer Center, Chinese Academy of Medi
Nov 23, 2023
Rectal Cancer Trial in Guangzhou (drug, procedure, radiation)
Recruiting
- Rectal Cancer
- Neoadjuvant chemotherapy with mFOLFOXIRI plus bevacizumab
- +5 more
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Sep 2, 2020
Metastatic Colorectal Cancer Trial in China (Cetuximab, Oxaliplatin, Folinic Acid)
Completed
- Metastatic Colorectal Cancer
- Cetuximab
- +3 more
-
Fuzhou, Fujian, China
- +24 more
Jan 16, 2020